Annual CFO
-$12.50 M
-$4.01 M-47.24%
31 December 2023
Summary:
BioLife Solutions annual cash flow from operations is currently -$12.50 million, with the most recent change of -$4.01 million (-47.24%) on 31 December 2023. During the last 3 years, it has fallen by -$19.14 million (-288.08%). BLFS annual CFO is now -288.08% below its all-time high of $6.64 million, reached on 31 December 2020.BLFS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$4.80 M
-$1.66 M-25.65%
30 September 2024
Summary:
BioLife Solutions quarterly cash flow from operations is currently $4.80 million, with the most recent change of -$1.66 million (-25.65%) on 30 September 2024. Over the past year, it has increased by +$9.18 million (+209.66%). BLFS quarterly CFO is now -38.88% below its all-time high of $7.86 million, reached on 31 December 2022.BLFS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$9.10 M
+$9.18 M+10929.76%
30 September 2024
Summary:
BioLife Solutions TTM cash flow from operations is currently $9.10 million, with the most recent change of +$9.18 million (+10929.76%) on 30 September 2024. Over the past year, it has increased by +$16.05 million (+230.85%). BLFS TTM CFO is now at all-time high.BLFS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.2% | +209.7% | +230.8% |
| 3 y3 years | -288.1% | +130.5% | +682.4% |
| 5 y5 years | -632.3% | +322.3% | +224.8% |
BLFS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -288.1% | at low | -38.9% | +148.4% | at high | +153.1% |
| 5 y | 5 years | -288.1% | at low | -38.9% | +148.4% | at high | +153.1% |
| alltime | all time | -288.1% | at low | -38.9% | +148.4% | at high | +153.1% |
BioLife Solutions Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.80 M(-25.7%) | $9.10 M(<-9900.0%) |
| June 2024 | - | $6.46 M(-244.3%) | -$84.00 K(-99.4%) |
| Mar 2024 | - | -$4.47 M(-293.6%) | -$14.26 M(+14.1%) |
| Dec 2023 | -$12.50 M(+47.2%) | $2.31 M(-152.8%) | -$12.50 M(+79.8%) |
| Sept 2023 | - | -$4.38 M(-43.3%) | -$6.95 M(+545.5%) |
| June 2023 | - | -$7.72 M(+184.6%) | -$1.08 M(-67.1%) |
| Mar 2023 | - | -$2.71 M(-134.5%) | -$3.28 M(-61.4%) |
| Dec 2022 | -$8.49 M(+84.8%) | $7.86 M(+425.2%) | -$8.49 M(-50.4%) |
| Sept 2022 | - | $1.50 M(-115.1%) | -$17.12 M(+3.6%) |
| June 2022 | - | -$9.92 M(+25.2%) | -$16.53 M(+15.3%) |
| Mar 2022 | - | -$7.92 M(+923.8%) | -$14.34 M(+212.1%) |
| Dec 2021 | -$4.59 M(-169.1%) | -$774.00 K(-137.2%) | -$4.59 M(+194.0%) |
| Sept 2021 | - | $2.08 M(-127.0%) | -$1.56 M(-62.3%) |
| June 2021 | - | -$7.72 M(-524.3%) | -$4.15 M(-153.3%) |
| Mar 2021 | - | $1.82 M(-19.4%) | $7.78 M(+17.1%) |
| Dec 2020 | $6.64 M(+447.8%) | $2.26 M(-549.6%) | $6.64 M(+96.3%) |
| Sept 2020 | - | -$502.00 K(-111.9%) | $3.38 M(-32.6%) |
| June 2020 | - | $4.20 M(+511.8%) | $5.02 M(+566.3%) |
| Mar 2020 | - | $687.00 K(-168.5%) | $754.00 K(-37.8%) |
| Dec 2019 | $1.21 M(-48.3%) | -$1.00 M(-188.2%) | $1.21 M(-56.7%) |
| Sept 2019 | - | $1.14 M(-1797.0%) | $2.80 M(+13.2%) |
| June 2019 | - | -$67.00 K(-105.8%) | $2.47 M(-20.2%) |
| Mar 2019 | - | $1.15 M(+95.9%) | $3.10 M(+32.1%) |
| Dec 2018 | $2.35 M(+288.1%) | $585.00 K(-27.8%) | $2.35 M(-8.5%) |
| Sept 2018 | - | $810.00 K(+44.4%) | $2.57 M(+40.2%) |
| June 2018 | - | $561.00 K(+43.1%) | $1.83 M(+56.9%) |
| Mar 2018 | - | $392.00 K(-51.2%) | $1.17 M(+92.8%) |
| Dec 2017 | $605.00 K(-114.0%) | $802.90 K(+979.2%) | $605.10 K(-169.9%) |
| Sept 2017 | - | $74.40 K(-172.3%) | -$865.90 K(-52.5%) |
| June 2017 | - | -$102.90 K(-39.2%) | -$1.82 M(-37.2%) |
| Mar 2017 | - | -$169.30 K(-74.7%) | -$2.90 M(-32.9%) |
| Dec 2016 | -$4.33 M(-13.0%) | -$668.10 K(-24.4%) | -$4.33 M(-12.2%) |
| Sept 2016 | - | -$883.70 K(-25.2%) | -$4.93 M(-5.5%) |
| June 2016 | - | -$1.18 M(-25.8%) | -$5.21 M(-0.9%) |
| Mar 2016 | - | -$1.59 M(+25.4%) | -$5.26 M(+5.7%) |
| Dec 2015 | -$4.97 M(+57.3%) | -$1.27 M(+8.7%) | -$4.97 M(+13.0%) |
| Sept 2015 | - | -$1.17 M(-4.8%) | -$4.40 M(+12.0%) |
| June 2015 | - | -$1.23 M(-6.2%) | -$3.93 M(+9.9%) |
| Mar 2015 | - | -$1.31 M(+87.7%) | -$3.58 M(+13.1%) |
| Dec 2014 | -$3.16 M(-2266.0%) | -$696.80 K(-0.2%) | -$3.16 M(+32.5%) |
| Sept 2014 | - | -$697.90 K(-20.1%) | -$2.39 M(+40.3%) |
| June 2014 | - | -$873.50 K(-2.3%) | -$1.70 M(+173.7%) |
| Mar 2014 | - | -$894.10 K(-1239.0%) | -$621.60 K(-525.8%) |
| Dec 2013 | $146.00 K(-82.9%) | $78.50 K(-728.0%) | $146.00 K(-38.2%) |
| Sept 2013 | - | -$12.50 K(-106.1%) | $236.30 K(-5.1%) |
| June 2013 | - | $206.50 K(-263.2%) | $248.90 K(-69.0%) |
| Mar 2013 | - | -$126.50 K(-174.9%) | $803.20 K(-6.0%) |
| Dec 2012 | $854.90 K(-186.4%) | $168.80 K(>+9900.0%) | $854.90 K(+73.3%) |
| Sept 2012 | - | $100.00(-100.0%) | $493.30 K(+105.6%) |
| June 2012 | - | $760.80 K(-1117.1%) | $239.90 K(-131.6%) |
| Mar 2012 | - | -$74.80 K(-61.2%) | -$760.10 K(-23.2%) |
| Dec 2011 | -$989.90 K(-21.0%) | -$192.80 K(-23.9%) | -$989.90 K(-8.1%) |
| Sept 2011 | - | -$253.30 K(+5.9%) | -$1.08 M(-5.4%) |
| June 2011 | - | -$239.20 K(-21.5%) | -$1.14 M(-3.5%) |
| Mar 2011 | - | -$304.60 K(+8.6%) | -$1.18 M(-5.8%) |
| Dec 2010 | -$1.25 M(-48.1%) | -$280.40 K(-10.9%) | -$1.25 M(+1.8%) |
| Sept 2010 | - | -$314.60 K(+12.3%) | -$1.23 M(-19.5%) |
| June 2010 | - | -$280.10 K(-25.8%) | -$1.53 M(-22.8%) |
| Mar 2010 | - | -$377.50 K(+46.0%) | -$1.98 M(-18.0%) |
| Dec 2009 | -$2.41 M(+14.2%) | -$258.50 K(-57.8%) | -$2.41 M(-11.8%) |
| Sept 2009 | - | -$612.80 K(-16.1%) | -$2.74 M(+5.6%) |
| June 2009 | - | -$730.50 K(-10.0%) | -$2.59 M(+7.6%) |
| Mar 2009 | - | -$811.80 K(+39.5%) | -$2.41 M(+13.9%) |
| Dec 2008 | -$2.11 M | -$582.10 K(+24.7%) | -$2.11 M(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2008 | - | -$466.90 K(-14.7%) | -$2.21 M(-17.2%) |
| June 2008 | - | -$547.40 K(+5.9%) | -$2.67 M(-1.0%) |
| Mar 2008 | - | -$517.00 K(-24.1%) | -$2.70 M(-0.4%) |
| Dec 2007 | -$2.71 M(+280.4%) | -$681.60 K(-26.5%) | -$2.71 M(+23.4%) |
| Sept 2007 | - | -$926.90 K(+61.7%) | -$2.19 M(+56.2%) |
| June 2007 | - | -$573.10 K(+8.7%) | -$1.40 M(+28.2%) |
| Mar 2007 | - | -$527.40 K(+214.9%) | -$1.10 M(+53.9%) |
| Dec 2006 | -$712.20 K(+23.6%) | -$167.50 K(+22.4%) | -$712.20 K(+5.2%) |
| Sept 2006 | - | -$136.80 K(-48.3%) | -$677.30 K(+3.5%) |
| June 2006 | - | -$264.50 K(+84.4%) | -$654.60 K(+19.1%) |
| Mar 2006 | - | -$143.40 K(+8.1%) | -$549.50 K(-4.7%) |
| Dec 2005 | -$576.30 K(-211.9%) | -$132.60 K(+16.2%) | -$576.40 K(+20.1%) |
| Sept 2005 | - | -$114.10 K(-28.4%) | -$479.90 K(-7.4%) |
| June 2005 | - | -$159.40 K(-6.4%) | -$518.40 K(+2.5%) |
| Mar 2005 | - | -$170.30 K(+371.7%) | -$505.90 K(-198.2%) |
| Dec 2004 | $515.10 K(-160.3%) | -$36.10 K(-76.3%) | $515.00 K(+264.7%) |
| Sept 2004 | - | -$152.60 K(+3.9%) | $141.20 K(-49.8%) |
| June 2004 | - | -$146.90 K(-117.3%) | $281.30 K(-15.1%) |
| Mar 2004 | - | $850.60 K(-307.5%) | $331.20 K(-138.8%) |
| Dec 2003 | -$854.20 K(-68.1%) | -$409.90 K(+3179.2%) | -$854.20 K(+8.9%) |
| Sept 2003 | - | -$12.50 K(-87.1%) | -$784.10 K(-66.4%) |
| June 2003 | - | -$97.00 K(-71.0%) | -$2.33 M(-12.2%) |
| Mar 2003 | - | -$334.80 K(-1.5%) | -$2.66 M(-0.6%) |
| Dec 2002 | -$2.68 M(+1.3%) | -$339.80 K(-78.3%) | -$2.68 M(+6.5%) |
| Sept 2002 | - | -$1.56 M(+270.3%) | -$2.51 M(+60.6%) |
| June 2002 | - | -$422.20 K(+19.9%) | -$1.57 M(-20.1%) |
| Mar 2002 | - | -$352.10 K(+99.7%) | -$1.96 M(-25.9%) |
| Dec 2001 | -$2.64 M(-8.8%) | -$176.30 K(-71.3%) | -$2.64 M(-24.6%) |
| Sept 2001 | - | -$615.20 K(-24.5%) | -$3.50 M(-4.3%) |
| June 2001 | - | -$815.00 K(-21.4%) | -$3.66 M(+5.7%) |
| Mar 2001 | - | -$1.04 M(-0.2%) | -$3.47 M(+19.6%) |
| Dec 2000 | -$2.90 M(+988.5%) | -$1.04 M(+34.1%) | -$2.90 M(+55.8%) |
| Sept 2000 | - | -$773.90 K(+25.3%) | -$1.86 M(+71.2%) |
| June 2000 | - | -$617.80 K(+31.8%) | -$1.09 M(+131.8%) |
| Mar 2000 | - | -$468.90 K(-463.2%) | -$468.90 K(-1711.3%) |
| Dec 1999 | -$266.30 K(-1015.1%) | - | - |
| Dec 1998 | $29.10 K(-101.9%) | $129.10 K(-164.5%) | $29.10 K(-109.9%) |
| Sept 1998 | - | -$200.00 K(-150.0%) | -$294.90 K(-40.4%) |
| June 1998 | - | $400.00 K(-233.3%) | -$494.90 K(-69.0%) |
| Mar 1998 | - | -$300.00 K(+53.9%) | -$1.59 M(+6.7%) |
| Dec 1997 | -$1.49 M(+10.5%) | -$194.90 K(-51.3%) | -$1.49 M(+15.0%) |
| Sept 1997 | - | -$400.00 K(-42.9%) | -$1.30 M(-13.3%) |
| June 1997 | - | -$700.00 K(+250.0%) | -$1.50 M(+39.8%) |
| Mar 1997 | - | -$200.00 K(-66.7%) | -$1.07 M(-56.6%) |
| Dec 1996 | -$1.35 M(-34.7%) | - | - |
| Sept 1996 | - | -$600.00 K(+119.7%) | -$2.47 M(+19.3%) |
| June 1996 | - | -$273.10 K(-80.5%) | -$2.07 M(+15.2%) |
| June 1996 | -$2.07 M(+34.4%) | - | - |
| Mar 1996 | - | -$1.40 M(+600.0%) | -$1.80 M(+350.0%) |
| Dec 1995 | - | -$200.00 K(0.0%) | -$400.00 K(+100.0%) |
| Sept 1995 | - | -$200.00 K(-50.0%) | -$200.00 K(-92.3%) |
| June 1995 | -$1.54 M(-40.7%) | - | - |
| Sept 1994 | - | -$400.00 K(-42.9%) | -$2.60 M(0.0%) |
| June 1994 | -$2.60 M(-69.0%) | -$700.00 K(+16.7%) | -$2.60 M(-40.9%) |
| Mar 1994 | - | -$600.00 K(-33.3%) | -$4.40 M(-17.0%) |
| Dec 1993 | - | -$900.00 K(+125.0%) | -$5.30 M(-23.2%) |
| Sept 1993 | - | -$400.00 K(-84.0%) | -$6.90 M(-17.9%) |
| June 1993 | -$8.40 M(+95.3%) | -$2.50 M(+66.7%) | -$8.40 M(+42.4%) |
| Mar 1993 | - | -$1.50 M(-40.0%) | -$5.90 M(+34.1%) |
| Dec 1992 | - | -$2.50 M(+31.6%) | -$4.40 M(+131.6%) |
| Sept 1992 | - | -$1.90 M(+171.4%) | -$1.90 M(+171.4%) |
| June 1992 | -$4.30 M(+72.0%) | - | - |
| June 1991 | -$2.50 M(+92.3%) | - | - |
| Sept 1990 | - | -$700.00 K | -$700.00 K |
| June 1990 | -$1.30 M | - | - |
FAQ
- What is BioLife Solutions annual cash flow from operations?
- What is the all time high annual CFO for BioLife Solutions?
- What is BioLife Solutions annual CFO year-on-year change?
- What is BioLife Solutions quarterly cash flow from operations?
- What is the all time high quarterly CFO for BioLife Solutions?
- What is BioLife Solutions quarterly CFO year-on-year change?
- What is BioLife Solutions TTM cash flow from operations?
- What is the all time high TTM CFO for BioLife Solutions?
- What is BioLife Solutions TTM CFO year-on-year change?
What is BioLife Solutions annual cash flow from operations?
The current annual CFO of BLFS is -$12.50 M
What is the all time high annual CFO for BioLife Solutions?
BioLife Solutions all-time high annual cash flow from operations is $6.64 M
What is BioLife Solutions annual CFO year-on-year change?
Over the past year, BLFS annual cash flow from operations has changed by -$4.01 M (-47.24%)
What is BioLife Solutions quarterly cash flow from operations?
The current quarterly CFO of BLFS is $4.80 M
What is the all time high quarterly CFO for BioLife Solutions?
BioLife Solutions all-time high quarterly cash flow from operations is $7.86 M
What is BioLife Solutions quarterly CFO year-on-year change?
Over the past year, BLFS quarterly cash flow from operations has changed by +$9.18 M (+209.66%)
What is BioLife Solutions TTM cash flow from operations?
The current TTM CFO of BLFS is $9.10 M
What is the all time high TTM CFO for BioLife Solutions?
BioLife Solutions all-time high TTM cash flow from operations is $9.10 M
What is BioLife Solutions TTM CFO year-on-year change?
Over the past year, BLFS TTM cash flow from operations has changed by +$16.05 M (+230.85%)